<DOC>
	<DOCNO>NCT00817505</DOCNO>
	<brief_summary>To evaluate bioavailability tablet AZD1656 .</brief_summary>
	<brief_title>To Evaluate Bioavailability Tablet AZD1656</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Male female , type I diabetes patient , female non childbearing potential . Treated insulin 3 year . Well controlled HbA1c . Have body mass index ( BMI ) ≥19 ≤35 Clinically significant illness except type I diabetes , clinically relevant trauma , judge investigator , within 2 week first administration investigational product Daily use nicotine contain substance .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Type I diabetes</keyword>
	<keyword>bioavailability</keyword>
</DOC>